πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 7 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12415794

Pyridazinone compounds and uses thereof

EDGEWISE THERAPEUTICS, INC. Β· Granted Tue Sep 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12240831

Pyridazinone compounds and uses thereof

EDGEWISE THERAPEUTICS, INC. Β· Granted Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12240833

Pyridazinone compounds and uses thereof

EDGEWISE THERAPEUTICS, INC. Β· Granted Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12012395

Pyridazinone compounds and uses thereof

EDGEWISE THERAPEUTICS, INC. Β· Granted Tue Jun 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11390606

Pyridazinone compounds and uses thereof

EDGEWISE THERAPEUTICS, INC. Β· Granted Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11236065

Pyridazinone compounds and uses thereof

EDGEWISE THERAPEUTICS, INC. Β· Granted Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11091464

Pyridazinone compounds and uses thereof

EDGEWISE THERAPEUTICS, INC. Β· Granted Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted